Did you mean category antidepressive agent an group approved?
Displaying drugs 9551 - 9575 of 10466 in total
Mdl-29951
Experimental
Di-Stearoyl-3-Sn-Phosphatidylcholine
Experimental
N-Methylleucine
Experimental
Fradafiban
Investigational
Tesaglitazar
Tesaglitazar is a dual peroxisome proliferator-activated receptor alpha/gamma agonist which improves apolipoprotein levels in non-diabetic subjects with insulin resistance. Tesaglitazar is a proposed treatment for type 2 diabetes and has completed several phase III clinical trials, however in May 2006 AstraZeneca announced that they had discontinued further development.
Investigational
Lidorestat
Investigational
S-palmitoyl-L-cysteine
Experimental
Arbaclofen
Arbaclofen, or STX209, is the R-enantiomer of baclofen. It is believed to be a selective gamma-amino butyric acid type B receptor agonist, and has been investigated as a treatment for autism spectrum disorder and fragile X syndrome in randomized, double blind, placebo controlled trials. It has also been investigated as...
Investigational
Linerixibat
GSK2330672 has been investigated for the treatment of Diabetes Mellitus, Type 2.
Investigational
RRx-001
RRx-001 has been used in trials studying the treatment of Lymphomas, Brain Metastases, Cholangiocarcinoma, Colorectal Neoplasms, and Malignant Solid Tumor, among others.
Investigational
L-Baclofen
L-Baclofen has been used in trials studying the treatment of Trigeminal Neuralgia.
Investigational
Fosdagrocorat
Fosdagrocorat has been used in trials studying the treatment and basic science of Rheumatoid Arthritis.
Investigational
Displaying drugs 9551 - 9575 of 10466 in total